Abstract
The author would like to alert readers to the following correction:
In the above referenced article, on page 5, first paragraph of column 2, we request that the sentence,
‘The patient had received DMF 240 mg three times daily for 2 years in the DEFINE clinical trial and was exposed to DMF 240 mg twice daily for 2.5 years in the ENDORSE open-label extension of the DEFINE clinical trial, for a total of 4.5 years of DMF treatment.’
be changed to
‘The patient had received DMF 240 mg three times daily for the first 2 years of ENDORSE and then was switched to DMF 240 mg twice daily for 2.5 years, for a total of 4.5 years of DMF treatment.’